New registry study data shows that long-term use of Dexcom G7 supports weight management and lowers A1C for people with Type 2 diabetes who aren’t on insulin therapy 1, reinforcing the need to broaden ...

Add Yahoo as a preferred source to see more of our stories on Google. Dexcom is poised to share new data on the benefits of its continuous glucose monitoring technology (CGM), which the company says ...

BARCELONA, Spain--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for ...

Adults in the US who want to measure their blood glucose levels using a wearable sensor will soon be able to buy one over-the-counter (OTC) for the first time. The FDA has cleared Dexcom’s Stelo as ...

Two years ago, Eli Lilly started working with Dexcom to integrate continuous glucose monitoring (CGM) into its insulin delivery devices, and it has now firmed up the alliance. Lilly has taken a ...

I’ve contributed to PCMag since 2019, covering all kinds of consumer electronics. As a self-identifying early adopter of technology, I’ve stumbled through the changing devices over the years and ...

The G7 15 Day CGM in use. [Image courtesy of Dexcom] BTIG analysts continue to expect growth from Dexcom (Nasdaq:DXCM) after meeting with the company’s senior investor relations (IR) officials. Marie ...

According to Dexcom, the company’s new data emphasises the case to expand its CGM for people with all types of diabetes. Credit: Michael Vi / Shutterstock.com Dexcom is poised to share new data on the ...

A man wears the Dexcom G7 on his arm while taking photographs. [Image courtesy of Dexcom] Dexcom (Nasdaq:DXCM) today announced its plans to share new data supporting its diabetes management technology ...

Nasha is a Managing Editor for CNET, overseeing our sleep and wellness verticals. She is a nutrition, mental health, fitness and sleep science enthusiast. Her passion for mindful and holistic ...